Conclusions: We established that low doses of rapamycin can hormetically amend the mTOR-mitochondria cross-talk, and can consequently promote anti-aging outcome in cells
6 Likes
Does this mitochondrial amendment overlap with NR/NMN uses?
2 Likes
Very interesting! I had not read that study.